Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Key biophysical attributes of a self-amplifying viral RNA vaccine developed for SARS-CoV-2

Researchers used various analytical characterization techniques to determine the biophysical attributes of the Imperial College London self-amplifying viral RNA vaccine (IMP-1) developed for SARS-CoV-2.

5 Oct 2022

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

Researchers engineered biparatopic nanobodies against SARS-CoV-2.

5 Oct 2022

Novel protein vaccine NVX-CoV2373 triggered functional T cell responses to SARS-CoV-2

Researchers determined the T cell response to the NVX-CoV2373, an adjuvanted recombinant full-length SARS-CoV-2 spike (S) trimer protein vaccine.

5 Oct 2022

What are the effects of the COVID-19 pandemic and SARS-CoV-2 infection on mental health?

In a new study, researchers reviewed the direct and indirect effects of coronavirus disease 2019 (COVID-19) and the COVID-19-induced pandemic on mental health.

5 Oct 2022

Impact of COVID-19 on diabetic ketoacidosis prevalence among children with type 1 diabetes

In a new study, researchers evaluated trends in diabetic ketoacidosis (DKA) prevalence at pediatric type 1 diabetes mellitus (T1D) diagnosis prior to and post-coronavirus disease 2019 (COVID-19).

5 Oct 2022

Study shows SARS-CoV-2 infects human adipose tissue and undergoes productive infection in fat cells

Researchers demonstrated infection of human adipose tissue by SARS-CoV-2.

5 Oct 2022

Omicron reduces host antibody response by lower B-cell antigenicity

A new study explores the functional relevance of some Omicron mutations in terms of their ability to escape neutralizing antibody responses.

4 Oct 2022

Antibody escape mutations of SARS-CoV-2 BA.2.75

A new study discusses how immune escape mutations allow a recent SARS-CoV-2 variant to evade neutralizing antibodies and cause breakthrough infections.

4 Oct 2022

Comparative immunogenicity of COVID-19 vaccines in North California

In new research, researchers evaluated vaccine responses among North Californian residents, including differences in vaccine side effects and antibody (Ab) titers by age, sex, and vaccine type.

4 Oct 2022

What is the COVID-19 mRNA-1273 vaccine effectiveness against SARS-CoV-2 Omicron sub-variants?

Researchers evaluated the messenger ribonucleic acid (mRNA)-1273 vaccine effectiveness against SARS-CoV-2 Omicron sub-variant of concern infections and hospitalizations.

4 Oct 2022

Model simulations for use of rapid antigen testing for COVID-19 diagnosis

In new research, researchers overviewed the impact of rapid antigen tests use cases with and without surveillance; hospital-based screening to decrease nosocomial COVID-19, and COVID-19 testing to enable prompt and expanded treatment for different country settings.

4 Oct 2022

Multiomic comparison shows a reduction in circulating monocytes correlated with persistent post-COVID-19 pulmonary fibrosis

In a new study, researchers identified distinguishing immune features of coronavirus disease 2019 (COVID-19) in patients with late-resolving pulmonary fibrosis (LR COVID-PF) and early-resolving (ER COVID-PF).

4 Oct 2022

What are the challenges of COVID-19 vaccination and herd immunity?

A new study reviewed the challenges of coronavirus disease 2019 (COVID-19) vaccination and herd immunity.

4 Oct 2022

Can you shed infectious SARS-CoV-2 virions even if COVID vaccinated?

Researchers in the United States published a study in the journal PLOS Pathogens that examined the shedding of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virions despite vaccination against it.

4 Oct 2022

Are infants younger than six months at higher risk of SARS-CoV-2 infections?

In a recent study posted to the medRxiv* preprint server, a team of researchers in the United States examined the incidence and associated characteristics of medically attended coronavirus disease 2019 (COVID-19) episodes in infants below six months of age.

4 Oct 2022

Nursing home study shows 4th COVID mRNA dose provides extra protection against severe Omicron outcomes

In a recent study posted to the medRxiv* preprint server, researchers in Canada assessed the effectiveness of protection elicited by the fourth dose of the coronavirus disease 2019 (COVID-19) mRNA vaccine.

4 Oct 2022

Spike-specific memory B cells develop resilience to SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, researchers explored the cross-reactivity, avidity, and kinetics of memory B-cells and serum antibodies in vaccinated and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected individuals.

4 Oct 2022

How COVID-19 affects the female reproductive system

A new review in the Biology of Reproduction journal analyzed the relationship between the immune system and the female reproductive system while focusing on the effects of COVID-19-associated immune responses on the reproductive system. The study searched PubMed to identify peer-reviewed literature in English up to May 2022 and finally included 83 studies.

3 Oct 2022

A case for updating COVID vaccines with beta variant spike sequences

A recent Nature Communications study has discussed preclinical and clinical data on COVID-19 vaccine antigens that could be utilized to develop effective booster vaccines.

3 Oct 2022

Researchers report aminoadamantanes that block SARS-CoV-2 infection by S-nitrosylation of the host ACE2 protein

Researchers investigated the use of aminoadamantane nitrate compounds as anti-SARS-CoV-2 drugs.

3 Oct 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Key biophysical attributes of a self-amplifying viral RNA vaccine developed for SARS-CoV-2

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

Novel protein vaccine NVX-CoV2373 triggered functional T cell responses to SARS-CoV-2

What are the effects of the COVID-19 pandemic and SARS-CoV-2 infection on mental health?

Impact of COVID-19 on diabetic ketoacidosis prevalence among children with type 1 diabetes

Study shows SARS-CoV-2 infects human adipose tissue and undergoes productive infection in fat cells

Omicron reduces host antibody response by lower B-cell antigenicity

Antibody escape mutations of SARS-CoV-2 BA.2.75

Comparative immunogenicity of COVID-19 vaccines in North California

What is the COVID-19 mRNA-1273 vaccine effectiveness against SARS-CoV-2 Omicron sub-variants?

Model simulations for use of rapid antigen testing for COVID-19 diagnosis

Multiomic comparison shows a reduction in circulating monocytes correlated with persistent post-COVID-19 pulmonary fibrosis

What are the challenges of COVID-19 vaccination and herd immunity?

Can you shed infectious SARS-CoV-2 virions even if COVID vaccinated?

Are infants younger than six months at higher risk of SARS-CoV-2 infections?

Nursing home study shows 4th COVID mRNA dose provides extra protection against severe Omicron outcomes

Spike-specific memory B cells develop resilience to SARS-CoV-2

How COVID-19 affects the female reproductive system

A case for updating COVID vaccines with beta variant spike sequences

Researchers report aminoadamantanes that block SARS-CoV-2 infection by S-nitrosylation of the host ACE2 protein

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in